Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
Acta Pharm Sin B ; 12(4): 2089-2102, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35847505

ABSTRACT

Red blood cells (RBCs) can act as carriers for therapeutic agents and can substantially improve the safety, pharmacokinetics, and pharmacodynamics of many drugs. Maintaining RBCs integrity and lifespan is important for the efficacy of RBCs as drug carrier. We investigated the impact of drug encapsulation by hypotonic dialysis on RBCs physiology and integrity. Several parameters were compared between processed RBCs loaded with l-asparaginase ("eryaspase"), processed RBCs without drug and non-processed RBCs. Processed RBCs were less hydrated and displayed a reduction of intracellular content. We observed a change in the metabolomic but not in the proteomic profile of processed RBCs. Encapsulation process caused moderate morphological changes and was accompanied by an increase of RBCs-derived Extracellular Vesicles release. Despite a decrease in deformability, processed RBCs were not mechanically retained in a spleen-mimicking device and had increased surface-to-volume ratio and osmotic resistance. Processed RBCs half-life was not significantly affected in a mouse model and our previous phase 1 clinical study showed that encapsulation of asparaginase in RBCs prolonged its in vivo half-life compared to free forms. Our study demonstrated that encapsulation by hypotonic dialysis may affect certain characteristics of RBCs but does not significantly affect the in vivo longevity of RBCs or their drug carrier function.

2.
Eur J Appl Physiol ; 120(1): 255-266, 2020 Jan.
Article in English | MEDLINE | ID: mdl-31776697

ABSTRACT

PURPOSE: Blood rheology is a key determinant of blood flow and tissue perfusion. There are still large discrepancies regarding the effects of an acute running exercise on blood rheological properties and red blood cell (RBC) physiology. We investigated the effect of a 10 km running trial on markers of blood rheology and RBC physiology in endurance trained athletes. METHODS: Blood was sampled before and after the exercise to measure lactate and glucose, hematological and hemorheological parameters (blood viscosity, RBC deformability, and aggregation), eryptosis markers (phosphatidylserine and CD47 exposure, RBC reactive oxygen species), RBC-derived microparticles (RBC-MPs), and RBC electrophysiological activity. Weight was measured before and after exercise. Peripheral oxygen saturation and heart rate were monitored before and during the trial. RESULTS: Blood lactate and glucose levels increased after exercise and subjects significantly lost weight. All athletes experienced a significant fall in oxygen saturation. Mean corpuscular volume (MCV) was increased from 95.1 ± 3.2 to 96.0 ± 3.3 and mean corpuscular hemoglobin concentration (MCHC) decreased after exercise suggesting a slight RBC rehydration. Exercise increased RBC deformability from 0.344 ± 0.04 to 0.378 ± 0.07, decreased RBC aggregates strength and blood viscosity, while hematocrit (Hct) remained unaffected. While RBC electrophysiological recording suggested a modulation in RBC calcium content and/or chloride conductance, eryptosis markers and RBC-MPs were not modified by the exercise. CONCLUSION: A 10 km acute running exercise had no effect on RBC senescence and membrane blebbing. In contrast, this exercise increased RBC deformability, probably through rehydration process which resulted in a decrease in blood viscosity.


Subject(s)
Eryptosis , Heart Rate , Hemorheology , Physical Conditioning, Human/methods , Running/physiology , Adult , Athletes , Blood Glucose/metabolism , Cell-Derived Microparticles/metabolism , Erythrocytes/metabolism , Female , Humans , Lactic Acid/blood , Male , Oxygen Consumption , Physical Conditioning, Human/adverse effects
3.
ACS Med Chem Lett ; 4(11): 1037-41, 2013 Nov 14.
Article in English | MEDLINE | ID: mdl-24900603

ABSTRACT

Recent observations on the emergence of artemisinin resistant parasites have highlighted the need for new antimalarial treatments. An HTS campaign led to the identification of the 1-(1-aminopropan-2-ol)carbazole analogues as potent hits against Plasmodium falciparum K1 strain. The SAR study and optimization of early ADME and physicochemical properties direct us to the selection of a late lead compound that shows good efficacy when orally administrated in the in vivo P. berghei mouse model.

4.
BMC Med Inform Decis Mak ; 12: 148, 2012 Dec 18.
Article in English | MEDLINE | ID: mdl-23249606

ABSTRACT

BACKGROUND: For selection and evaluation of potential biomarkers, inclusion of already published information is of utmost importance. In spite of significant advancements in text- and data-mining techniques, the vast knowledge space of biomarkers in biomedical text has remained unexplored. Existing named entity recognition approaches are not sufficiently selective for the retrieval of biomarker information from the literature. The purpose of this study was to identify textual features that enhance the effectiveness of biomarker information retrieval for different indication areas and diverse end user perspectives. METHODS: A biomarker terminology was created and further organized into six concept classes. Performance of this terminology was optimized towards balanced selectivity and specificity. The information retrieval performance using the biomarker terminology was evaluated based on various combinations of the terminology's six classes. Further validation of these results was performed on two independent corpora representing two different neurodegenerative diseases. RESULTS: The current state of the biomarker terminology contains 119 entity classes supported by 1890 different synonyms. The result of information retrieval shows improved retrieval rate of informative abstracts, which is achieved by including clinical management terms and evidence of gene/protein alterations (e.g. gene/protein expression status or certain polymorphisms) in combination with disease and gene name recognition. When additional filtering through other classes (e.g. diagnostic or prognostic methods) is applied, the typical high number of unspecific search results is significantly reduced. The evaluation results suggest that this approach enables the automated identification of biomarker information in the literature. A demo version of the search engine SCAIView, including the biomarker retrieval, is made available to the public through http://www.scaiview.com/scaiview-academia.html. CONCLUSIONS: The approach presented in this paper demonstrates that using a dedicated biomarker terminology for automated analysis of the scientific literature maybe helpful as an aid to finding biomarker information in text. Successful extraction of candidate biomarkers information from published resources can be considered as the first step towards developing novel hypotheses. These hypotheses will be valuable for the early decision-making in the drug discovery and development process.


Subject(s)
Biomarkers , Data Mining , Terminology as Topic , Algorithms , Humans , Search Engine
5.
Front Immunol ; 3: 293, 2012.
Article in English | MEDLINE | ID: mdl-23087686

ABSTRACT

Heparin, a glycosaminoglycan (GAG), has both anti-inflammatory and anti-coagulant properties. The clinical use of heparin against inflammation, however, has been limited by concerns about increased bleeding. While the anti-coagulant activity of heparin is well understood, its anti-inflammatory properties are less so. Heparin is known to bind to certain cytokines, including chemokines, small proteins which mediate inflammation through their control of leukocyte migration and activation. Molecules which can interrupt the chemokine-GAG interaction without inhibiting coagulation could therefore, represent a new class of anti-inflammatory agents. In the present study, two approaches were undertaken, both focusing on the heparin-chemokine relationship. In the first, a structure based strategy was used: after an initial screening of potential small molecule binders using protein NMR on a target chemokine, binding molecules were optimized through structure-based design. In the second approach, commercially available short oligosaccharides were polysulfated. In vitro, these molecules prevented chemokine-GAG binding and chemokine receptor activation without disrupting coagulation. However, in vivo, these compounds caused variable results in a murine peritoneal recruitment assay, with a general increase of cell recruitment. In more disease specific models, such as antigen-induced arthritis and delayed-type hypersensitivity, an overall decrease in inflammation was noted, suggesting that the primary anti-inflammatory effect may also involve factors beyond the chemokine system.

6.
Expert Opin Drug Discov ; 5(2): 117-22, 2010 Feb.
Article in English | MEDLINE | ID: mdl-22822911

ABSTRACT

The number of new drug approvals per year has been decreasing consistently over the past decade. Although this is due in part to an increase in regulatory requirements, it should also be recognized that the pharmaceutical industry is struggling to feed R&D pipelines with novel molecular entities. The innovation gap is widening as the density and complexity of biomedical information often prevents researchers from efficiently extracting relevant knowledge to foster innovation and support informed decision making. In this article, we discuss how a biomedical knowledge compilation strategy focused around disease can provide a framework to enhance productivity within the pharmaceutical industry. The aim is to systematically structure multidisciplinary data in a pathophysiologically-relevant context in order to maximize its therapeutic potential. We predict that in this way the industry should finally be able to leverage on a return on investment from the -omics fields and high-throughput technologies that have failed to live up to its expectations in recent years. Furthermore, we expect that the proposed strategic change in the way biomedical information is managed will support the development of future in silico and systems biology approaches and promote translational research.

7.
Biochemistry ; 48(27): 6379-89, 2009 Jul 14.
Article in English | MEDLINE | ID: mdl-19507895

ABSTRACT

Malaria remains a major killer in many parts of the world. Recently, there has been an increase in the role of public-private partnerships inciting academic and industrial scientists to merge their expertise in drug-target validation and in the early stage of drug discovery to identify potential new medicines. There is a need to identify and characterize new molecules showing high efficacy, low toxicity with low propensity to induce resistance in the parasite. In this context, we have studied the structural requirements of the inhibition of PfCDPK1. This is a calcium-dependent protein kinase expressed in Plasmodium falciparum, which has been genetically confirmed as essential for survival. A primary screening assay has been developed. A total of 54000 compounds were tested, yielding two distinct chemical series of nanomolar small molecule inhibitors. The most potent members of each series were further characterized through enzymatic and biophysical analyses. Dissociation rates of the inhibitor-kinase complexes were shown to be key parameters to differentiate both series. Finally, a homology-based model of the kinase core domain has been built which allows rational design of the next generation of inhibitors.


Subject(s)
Plasmodium falciparum/enzymology , Protein Kinase Inhibitors/pharmacology , Protozoan Proteins/antagonists & inhibitors , Animals , Luminescence , Models, Molecular , Protein Kinase Inhibitors/chemistry , Protein Kinases/isolation & purification , Protein Kinases/metabolism , Protozoan Proteins/isolation & purification , Protozoan Proteins/metabolism , Substrate Specificity
8.
Antimicrob Agents Chemother ; 52(10): 3710-7, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18644955

ABSTRACT

Development of a safe, effective, and inexpensive therapy for African trypanosomiasis is an urgent priority. In this study, we evaluated the validity of Trypanosoma brucei glycogen synthase kinase 3 (GSK-3) as a potential drug target. Interference with the RNA of either of two GSK-3 homologues in bloodstream-form T. brucei parasites led to growth arrest and altered parasite morphology, demonstrating their requirement for cell survival. Since the growth arrest after RNA interference appeared to be more profound for T. brucei GSK-3 "short" (Tb10.161.3140) than for T. brucei GSK-3 "long" (Tb927.7.2420), we focused on T. brucei GSK-3 short for further studies. T. brucei GSK-3 short with an N-terminal maltose-binding protein fusion was cloned, expressed, and purified in a functional form. The potency of a GSK-3-focused inhibitor library against the recombinant enzyme of T. brucei GSK-3 short, as well as bloodstream-form parasites, was evaluated with the aim of determining if compounds that inhibit enzyme activity could also block the parasites' growth and proliferation. Among the compounds active against the cell, there was an excellent correlation between activity inhibiting the T. brucei GSK-3 short enzyme and the inhibition of T. brucei growth. Thus, there is reasonable genetic and chemical validation of GSK-3 short as a drug target for T. brucei. Finally, selective inhibition may be required for therapy targeting the GSK-3 enzyme, and a molecular model of the T. brucei GSK-3 short enzyme suggests that compounds that selectively inhibit T. brucei GSK-3 short over the human GSK-3 enzymes can be found.


Subject(s)
Glycogen Synthase Kinase 3/antagonists & inhibitors , Trypanosoma brucei brucei/drug effects , Trypanosoma brucei brucei/enzymology , Trypanosomiasis, African/drug therapy , Trypanosomiasis, African/parasitology , Animals , Base Sequence , DNA Primers/genetics , DNA, Protozoan/genetics , Genes, Protozoan , Glycogen Synthase Kinase 3/chemistry , Glycogen Synthase Kinase 3/genetics , Glycogen Synthase Kinase 3/metabolism , Humans , Models, Molecular , Protein Kinase Inhibitors/pharmacology , RNA Interference , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Species Specificity , Trypanosoma brucei brucei/genetics
9.
J Med Chem ; 51(7): 2227-43, 2008 Apr 10.
Article in English | MEDLINE | ID: mdl-18318469

ABSTRACT

A novel chemical class of potent chemoattractant receptor-homologous expressed on Th2 lymphocytes (CRTH2 or DP2) antagonists is reported. An initial and moderately potent spiro-indolinone compound ( 5) was found during a high-throughput screening campaign. Structure-activity relationship (SAR) investigation around the carboxylic acid group revealed that changes in this part of the molecule could lead to a reversal of functional activity, yielding weakly potent agonists. SAR investigation of the succinimide functional group led to the discovery of several single-digit nanomolar antagonists. The potency of these compounds was confirmed in a human eosinophil chemotaxis assay. Moreover, compounds ( R)- 58 and ( R)- 71 were shown to possess pharmacokinetic properties suitable for development as an orally bioavailable drug.


Subject(s)
Hypersensitivity/drug therapy , Indoles/classification , Indoles/pharmacology , Receptors, Immunologic/antagonists & inhibitors , Receptors, Prostaglandin/antagonists & inhibitors , Spiro Compounds/classification , Spiro Compounds/pharmacology , Animals , Binding Sites , Caco-2 Cells , Cell Membrane Permeability/drug effects , Crystallography, X-Ray , Cytochrome P-450 Enzyme Inhibitors , Dogs , Drug Design , Humans , Indoles/chemistry , Inflammation/drug therapy , Male , Microsomes/drug effects , Microsomes/metabolism , Models, Molecular , Molecular Structure , Rats , Rats, Sprague-Dawley , Spiro Compounds/chemistry , Stereoisomerism , Structure-Activity Relationship
10.
Am J Obstet Gynecol ; 197(1): 54.e1-9, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17618756

ABSTRACT

OBJECTIVE: The purpose of this study was to assess the tocolytic effect of AS604872, an orally active, potent, and selective prostanoid prostaglandin F2alpha receptor (FP) antagonist. STUDY DESIGN: Compound AS604872 was characterized and tested for its ability to block uterine contraction and delay preterm parturition in rodent models. RESULTS: AS604872 inhibited spontaneous uterine contractions in pregnant rat near term. In pregnant mouse, AS604872 delayed parturition induced by either the antiprogesterone RU-486 or the endotoxin lipopolysaccharide. Pups from treated mothers were delivered alive. The efficacy of AS604872 was superior to the beta-mimetic drug ritodrine. Combination of AS604872 and ritodrine showed an additive inhibitory effect on spontaneous uterine contractions in rat. CONCLUSION: A selective antagonist of the FP receptor suppresses uterine contractility and delays labor. Our findings identify a new potential modality for the pharmacological management of preterm labor.


Subject(s)
Biphenyl Compounds/pharmacology , Obstetric Labor, Premature/prevention & control , Receptors, Prostaglandin/antagonists & inhibitors , Sulfonamides/pharmacology , Tocolytic Agents/pharmacology , Uterine Contraction/drug effects , Animals , Drug Therapy, Combination , Female , Humans , Mice , Mifepristone/pharmacology , Pregnancy , Rats , Rats, Sprague-Dawley , Ritodrine/pharmacology , Treatment Outcome
11.
J Recept Signal Transduct Res ; 27(1): 83-97, 2007.
Article in English | MEDLINE | ID: mdl-17365511

ABSTRACT

The development of new analytical methods, aimed at profiling G protein-coupled receptor (GPCR) ligands, regardless of the G protein-coupling pattern of their respective receptor, remains a key goal in drug discovery. Considerable evidence has recently revived the central role that could be played by extracellular-signal-regulated kinase (ERK), the cornerstone protein kinase of the first tyrosine kinase receptor-mediated pathway identified, in response to the activation of various types of GPCRs. Here we reveal a conceptual study in which the potential of ERK phosphorylation is evaluated as a generic readout in response to three different receptors activating three main classes of G proteins: Galphas, Galphai and Galphaq. GPCR-mediated ERK phosphorylation was compared with different readouts such as GTPgammaS, CAMP, or Ca2 +. We propose the measurement of GPCR-activated ERK phosphorylation as an alternative assay to better understand the molecular pharmacology of ligands of promiscuous GPCRs.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , GTP-Binding Proteins/metabolism , Receptors, G-Protein-Coupled/metabolism , Signal Transduction , Animals , CHO Cells , Cricetinae , Cricetulus , Enzyme Activation , Ligands , Phosphorylation
12.
Assay Drug Dev Technol ; 4(5): 525-33, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17115923

ABSTRACT

Type II diabetes and its associated complications are a major health concern of the developed world. One of the hallmarks of diabetes is insulin resistance, where secreted insulin no longer has any effect on its target tissues, namely, liver, muscle, and fat. An important therapeutic strategy is to modulate blood glucose levels using pharmacological agents. Glycogen synthase kinase-3 (GSK3) is a serine-threonine protein kinase that plays important roles in regulating glucose metabolism. It is a key negative regulator of insulin action and is an important contributing factor to insulin resistance in liver, muscle, and adipose tissue. We describe the development of a cell-based assay designed to measure glucose production in rat hepatoma cell line H4IIE liver cells in response to treatment with small molecule inhibitors, including GSK3 inhibitors. The assay is set up in a 96-well format, and glucose production is assessed using a convenient fluorescence-based readout. This disease-relevant cellular assay is a valuable tool for the progression of small molecules that modulate glucose production.


Subject(s)
Biological Assay/methods , Glucose/metabolism , Glycogen Synthase Kinase 3/metabolism , Insulin/administration & dosage , Liver Neoplasms, Experimental/metabolism , Animals , Cell Line, Tumor , Dose-Response Relationship, Drug , Drug Design , Metabolic Clearance Rate/drug effects , Rats
13.
J Biomol Screen ; 11(8): 996-1004, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17092920

ABSTRACT

Protein tyrosine phosphatases (PTPs) play key roles in regulating tyrosine phosphorylation levels in cells. Since the discovery of PTP1B as a major drug target for diabetes and obesity, PTPs have emerged as a new and promising class of signaling targets for drug development in a variety of therapeutic areas. The routine use of generic substrate 6,8-difluoro-4-methylumbelliferyl phosphate (DiFMUP) in our hands led to the discovery of very similar and often not very selective molecules. Therefore, to increase the chances to discover novel chemical scaffolds, a side-by-side comparison between the DiFMUP assay and a chip-based mobility shift assay with a specific phosphopeptide was performed, on 1 PTP, using a focused set of compounds. Assay robustness and sensitivity were comparable for both the DiFMUP and mobility shift assays. The off-chip mobility shift assay required a longer development time because of identification, synthesis, and characterization of a specific peptide, and its cost per point was higher. However, although most potent scaffolds found with the DiFMUP assay were confirmed in the mobility shift format, the off-chip mobility shift assay led to the identification of previously unidentified chemical scaffolds with improved druglike properties.


Subject(s)
Electrophoretic Mobility Shift Assay/methods , Microfluidics/methods , Protein Tyrosine Phosphatases/antagonists & inhibitors , Drug Evaluation, Preclinical/methods , Peptidyl Transferases , Structure-Activity Relationship , Vanadates/chemistry
14.
Assay Drug Dev Technol ; 4(4): 451-60, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16945017

ABSTRACT

Glycogen synthase kinase-3 (GSK3) is a serine-threonine protein kinase that exists as two isozymes, GSK3alpha and GSK3beta. It plays important roles in regulating cell structure, function, and survival, and dysregulation of its function is linked to disorders such as Alzheimer's disease and type II diabetes. In resting cells, GSK3 is active and regulates the function of many downstream targets, including beta-catenin. We describe the development of a cell-based assay designed to measure the activity of GSK3 by directly measuring the accumulation of beta-catenin in Chinese hamster ovary clone K1 (CHOK1) cells. Beta-catenin levels were assessed using an antibody-based staining protocol with a luminometric readout. The assay is set up in a 96-well format. The use of GSK3 inhibitors demonstrated that this assay could be used to compare the effects of various small molecules on GSK3 inhibition in CHOK1 cells.


Subject(s)
Glycogen Synthase Kinase 3/antagonists & inhibitors , Glycogen Synthase Kinase 3/metabolism , beta Catenin/metabolism , Aminophenols/pharmacology , Animals , Benzazepines/pharmacology , Benzimidazoles/pharmacology , Blotting, Western , CHO Cells , Clone Cells , Cricetinae , Cricetulus , Dimethyl Sulfoxide/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/chemistry , Enzyme Inhibitors/pharmacology , Eukaryotic Initiation Factor-2B/metabolism , Glycogen Synthase Kinase 3/chemistry , Humans , Imidazoles/pharmacology , Immunoblotting , Indoles/pharmacology , Lithium Chloride/pharmacology , Luminescent Measurements/methods , Maleimides/pharmacology , Pyridines/pharmacology , Pyrimidines/pharmacology , Reproducibility of Results , beta Catenin/chemistry
15.
J Biomol Screen ; 11(4): 359-68, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16751332

ABSTRACT

Kinases are key targets for drug discovery. In the field of screening in general and especially in the kinase area, because of considerations of efficiency and cost, radioactivity-based assays tend to be replaced by alternative, mostly fluorescence-based, assays. Today, the limiting factor is rarely the number of data points that can be obtained but rather the quality of the data, enzyme availability, and cost. In this article, the authors describe the development of an assay for a kinase screen based on the electrophoretic separation of fluorescent product and substrate using a Caliper-based nanofluidics environment in on-chip incubation mode. The authors present the results of screening a focused set of 32,000 compounds together with confirmation data obtained in a filtration assay. In addition, they have made a small-scale comparison between the on-chip and off-chip nanofluidics screening modes. In their hands, the screen in on-chip mode is characterized by high precision most likely due to the absence of liquid pipetting; an excellent confirmation rate (62%) in an independent assay format, namely, filtration; and good sensitivity. This study led to the identification of 4 novel chemical series of inhibitors.


Subject(s)
Drug Evaluation, Preclinical/methods , Microfluidic Analytical Techniques/methods , Protein Serine-Threonine Kinases/antagonists & inhibitors , Drug Evaluation, Preclinical/statistics & numerical data , Electrophoresis, Microchip/methods , Electrophoresis, Microchip/statistics & numerical data , In Vitro Techniques , Kinetics , Microfluidic Analytical Techniques/statistics & numerical data , Reproducibility of Results
16.
Assay Drug Dev Technol ; 4(2): 185-96, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16712422

ABSTRACT

In the field of screening in general and especially in the kinase area, taking into consideration throughput and cost, fluorescence- and luminescence-based assays have been developed as alternatives to radioactivity-based assays. However, fluorescence-based technologies are not devoid of pitfalls. One of the main problems is interference from autofluorescent compounds and the incidence of false-positives as exemplified here with a fluorescence polarization (FP)-based assay. Using the scintillation proximity assay as the in-house standard, we assessed several alternatives to radioactive methods, namely, the amplified luminescent proximity homogeneous assay screen (ALPHAScreen, Perkin-Elmer Life Sciences, Boston, MA), enzyme fragment complementation, FP, and nanofluidics-based fluorescence intensity. Data comparing the sensitivity, robustness, relative sensitivity to autofluorescent compounds, enzyme consumption, and relative costs of each assay for one common kinase are presented. Results obtained seem to favor the nanofluidics mobility shift assay as a method of choice, followed by the direct FP approach, using generic high-molecular-weight phosphate group-binders.


Subject(s)
Fluorescence Polarization Immunoassay , Protein Serine-Threonine Kinases/analysis , Fluorescent Dyes , Luminescent Measurements/methods , Microfluidic Analytical Techniques/methods , Protein Serine-Threonine Kinases/antagonists & inhibitors , Scintillation Counting/methods , Sensitivity and Specificity
17.
Nat Rev Drug Discov ; 5(4): 343-56, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16582878

ABSTRACT

Traditional screening paradigms often focus on single targets. To facilitate drug discovery in the more complex physiological environment of a cell or organism, powerful cellular imaging systems have been developed. The emergence of these detection technologies allows the quantitative analysis of cellular events and visualization of relevant cellular phenotypes. Cellular imaging facilitates the integration of complex biology into the screening process, and addresses both high-content and high-throughput needs. This review describes how cellular imaging technologies contribute to the drug discovery process.


Subject(s)
Drug Design , Microscopy, Confocal , Microscopy, Fluorescence , Animals , Biomarkers , Flow Cytometry , Fluorescent Dyes , Humans , Micronucleus Tests
18.
Expert Opin Drug Discov ; 1(3): 195-8, 2006 Aug.
Article in English | MEDLINE | ID: mdl-23495840

ABSTRACT

The last decade showed a further upsurge in screening technology advance and innovation. Notably, the establishment of ultra high-throughput screening facilities led to an explosion of screening capacities. However, in the last 2 years, a turning point in screening philosophy can be observed worldwide. Increasingly more companies are reducing the size of screening campaigns, while increasing the emphasis on data quality and relevance. This article tries to investigate how screening technologies will develop in the ever-changing landscape of drug discovery.

19.
J Med Chem ; 48(24): 7882-905, 2005 Dec 01.
Article in English | MEDLINE | ID: mdl-16302826

ABSTRACT

We report a novel chemical class of potent oxytocin receptor antagonists showing a high degree of selectivity against the closely related vasopressin receptors (V1a, V1b, V2). An initial compound, 7, was shown to be active in an animal model of preterm labor when administered by the intravenous but not by the oral route. Stepwise SAR investigations around the different structural elements revealed one position, the arenesulfonyl moiety, to be amenable to structural changes. Consequently, this position was used to introduce a variety of substituents to improve the physicochemical properties. Some of the resulting analogues were found to be superior to 7 both in terms of potency in vitro and aqueous solubility, which translated into significantly improved efficacy in the animal model after intravenous and oral administration. The best compound, 73, potently inhibited oxytocin-induced uterine contractions in nonpregnant rats and reduced spontaneous uterine contractions in late-term pregnant rats.


Subject(s)
Hydrazines/chemical synthesis , Receptors, Oxytocin/antagonists & inhibitors , Sulfonamides/chemical synthesis , Administration, Oral , Animals , Antidiuretic Hormone Receptor Antagonists , Binding, Competitive , Cell Line , Cricetinae , Cricetulus , Female , Humans , Hydrazines/chemistry , Hydrazines/pharmacology , In Vitro Techniques , Obstetric Labor, Premature/physiopathology , Obstetric Labor, Premature/prevention & control , Pregnancy , Radioligand Assay , Rats , Rats, Sprague-Dawley , Structure-Activity Relationship , Sulfonamides/chemistry , Sulfonamides/pharmacology , Uterine Contraction/drug effects
20.
Biochemistry ; 44(30): 9990-10008, 2005 Aug 02.
Article in English | MEDLINE | ID: mdl-16042376

ABSTRACT

The human oxytocin receptor is known to exhibit promiscuous activity by coupling to both Galpha(q) and Galpha(i) G proteins to activate distinct signaling pathways. A single-amino acid substitution within the highly conserved E/DRY motif at the cytosolic extension of helix 3 [i.e., D136(3.49)N] increased the rate of both basal and agonist-stimulated inositol phosphate (IP(3)) accumulation of the receptor. Furthermore, like for a typical constitutively active receptor, the partial agonist arginine vasopressin behaved as a full agonist for the D136(3.49)N mutant. Subsequently, both oxytocin and arginine vasopressin showed an increased potency in stimulating IP3 accumulation as compared to the wild-type receptor. Very interestingly, our experiments provide strong evidence that the D136(3.49)N mutant inhibits receptor signaling via Galpha(i)-mediated pathways while increasing the activity through the Galpha(q)-mediated pathways. Molecular simulations of the free and OT-bound forms of wild-type OTR and of the D136(3.49)N constitutively active mutant suggest that the receptor portions close to the E/DRY and NPxxY motifs are particularly susceptible to undergoing structural modification in response to activating mutations and agonist binding. Furthermore, computational modeling suggests that the OT-bound form of wild-type OTR is able to explore more states than the OT-bound form of the D136(3.49)N constitutively active mutant, consistent with its G protein promiscuity. Taken together, these observations emphasize the important role of the E/DRY motif not only in receptor activation but also in the promiscuity of G protein coupling. Knowledge of the mechanism of selective G protein coupling could aid drug discovery efforts to identify signaling specific therapies.


Subject(s)
Receptors, Oxytocin/chemistry , Receptors, Oxytocin/physiology , Signal Transduction , Amino Acid Motifs/genetics , Amino Acid Sequence , Amino Acid Substitution/genetics , Animals , Arginine/genetics , Asparagine/genetics , COS Cells , Cell Line , Computational Biology , Computer Simulation , Humans , Models, Molecular , Molecular Sequence Data , Mutagenesis, Site-Directed , Oxytocin/chemistry , Oxytocin/metabolism , Protein Binding/genetics , Receptors, Oxytocin/genetics , Signal Transduction/genetics , Tyrosine/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...